Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH) Key Ratios
$0.28
As on 25-Nov-2025 09:30EDT
Market cap
$13 Mln
Revenue (TTM)
$315 Mln
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -30.00 | -68.75 | -36.36 | -27.60 | -36.11 |
| EBIT | -13.33 | 56.96 | 57.24 | -232.72 | -187.90 |
| Net Profit | -23.33 | 41.15 | 37.29 | -219.01 | -199.02 |
| EPS | -23.25 | -20.83 | 25.06 | -215.92 | -210.69 |
| Book Value | -- | -- | 48.75 | 66.37 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| 30.42 | -- | 33.32 | 48.03 | 9.91 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 31.72 | -- | 38.00 | 146.56 | -89.41 |
| Return on Capital
| 23.92 | -- | 36.53 | 139.63 | -104.39 |
| Return on Assets
| 21.94 | -- | 17.90 | 35.62 | 12.29 |
| Debt to Equity (x)
| -- | -- | 0.05 | 0.03 | 0.17 |
Profitability
ROCE
36.53
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
36.53
|
139.63
|
-104.39
|
--
|
-12.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
38.00
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
38.00
|
146.56
|
-89.41
|
--
|
-23.59
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
17.90
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
17.90
|
35.62
|
12.29
|
--
|
-7.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
33.32
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
33.32
|
48.03
|
9.91
|
-51.99
|
-64.91
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
20.09
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
20.09
|
34.65
|
9.97
|
-52.09
|
-42.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-0.03
--
Year on year growth in net sales
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
-0.03
|
0.28
|
1.06
|
--
|
-0.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-32.79
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
-32.79
|
520.88
|
139.30
|
--
|
5.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-43.83
--
Year on year growth in profit after tax
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
-43.83
|
345.40
|
139.44
|
--
|
-0.52
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.44
--
Year on year growth in earnings per share
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
-0.44
|
3.45
|
1.39
|
--
|
-0.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.05
--
Total debt / Net worth
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
0.05
|
0.03
|
0.17
|
-0.06
|
0.27
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
0.01
|
0.02
|
0.17
|
-0.03
|
1.43
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.87
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
1.87
|
1.75
|
0.96
|
0.41
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.82
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
1.82
|
1.67
|
0.92
|
0.14
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
--
|
--
|
980.43
|
-405.37
|
-4.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
46.59
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
46.59
|
28.91
|
79.49
|
8.56
|
17.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.89
--
Sales / Average Total Assets
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
0.89
|
1.03
|
1.23
|
--
|
0.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
139.57
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
139.57
|
166.10
|
152.75
|
15,315.53
|
57.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
156.47
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
156.47
|
111.60
|
147.30
|
158,652.26
|
295.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
206.83
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
206.83
|
191.96
|
78.57
|
22,942.04
|
35.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
89.21
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
89.21
|
85.74
|
221.48
|
151,025.74
|
317.19
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
429.87
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
429.87
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
136.59
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
136.59
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
251.40
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-17
|
|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
251.40
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|